Acetylcholinesterase inhibitors (ChEIs) and N-methyl-d-aspartate (NMDA) receptor antagonists are currently the only approved drugs for AD treatment, but these drugs do not reverse the progression of disease [3]. The gene discussed is ACHE; the disease is Alzheimer disease.